Evidence map›Paper›PMID 34777071›Full record

ArticleFrontiers in psychiatry2021

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry.

Danilo De Gregorio, Mirella Ruggeri, Sagnik Bhattacharyya, Marco Colizzi

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Danilo De GregorioNeurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada.
Mirella RuggeriSection of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Sagnik BhattacharyyaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Marco ColizziSection of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Funding

Medical Research Council MC_PC_14105Medical Research Council MR/J012149/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

addiction and substance use disordercannabidiol (CBD)cannabinoid (CB) receptorsgeneticslaboratory modelmagnetic resonance imaging (MRI)perinatal and neurodevelopmental abnormalitiespsychosis and depressive disorder

Identifiers

PMID34777071
PMCPMC8581171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.